Comparison of 3 Paclitaxel-Based Chemoradiotherapy Regimens for Patients With Locally Advanced Esophageal Squamous Cell Cancer: A Randomized Clinical Trial

IMPORTANCE: Multiple paclitaxel-based regimens are widely used in chemoradiation therapy against esophageal cancer, including regimens combining paclitaxel with fluorouracil, cisplatin, and carboplatin. However, which among these 3 regimens provides the best prognosis with minimum adverse events is...

Descripción completa

Detalles Bibliográficos
Autores principales: Ai, Dashan, Ye, Jinjun, Wei, Shihong, Li, Yunhai, Luo, Hui, Cao, Jianzhong, Zhu, Zhengfei, Zhao, Weixin, Lin, Qin, Yang, Huanjun, Zheng, Xiangpeng, Zhou, Jialiang, Huang, Guang, Li, Ling, Li, Jiancheng, Zhang, Zhi, Zhou, Guoren, Gu, Dayong, Du, Mingyu, Mo, Miao, Jia, HuiXun, Zhang, Zhen, Zhao, Kuaile
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861838/
https://www.ncbi.nlm.nih.gov/pubmed/35188552
http://dx.doi.org/10.1001/jamanetworkopen.2022.0120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861838/
https://www.ncbi.nlm.nih.gov/pubmed/35188552
http://dx.doi.org/10.1001/jamanetworkopen.2022.0120

Ejemplares similares